Skip to main content
Clinical Trials/ACTRN12612000785808
ACTRN12612000785808WithdrawnPhase 4

The chronic effects of Bacopa on cognitive performance in Alzheimer's patients - A pilot study

Swinburne University of Technology0 sites40 target enrollmentStarted: July 24, 2012Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Withdrawn
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
60 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Diagnosis of mild to moderate Alzheimer's disease
  • Aged 60 and above

Exclusion Criteria

  • less than 60 years of age
  • History of, or current psychiatric illness
  • Neurological diseases (other than Alzheimers)
  • Suffering from Endocrine, gastrointestinal or bleeding disorders
  • A history of chronic illness or infection
  • Pregnant or lactating
  • current use of medications including; anticoagulants, antidepressants, anti-psychotics, anxyolitics, anti-parkinsons.
  • current use of illicit drugs, cognitive enhancing drugs, or vitamin and herbal supplements

Investigators

Similar Trials